Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis og 579 patients treated with epirubicin-based chemoterapy

Marianne Ryberg; Dorte Nielsen; Kell Osterlind; Per Kragh Andersen; T. Skovsgaard; Per Dombernowsky

Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis og 579 patients treated with epirubicin-based chemoterapy

Marianne Ryberg, Dorte Nielsen, Kell Osterlind, Per Kragh Andersen, T. Skovsgaard, Per Dombernowsky

Biostatistisk afdeling

Abstract

breast cancer; CNS metastases; competing risk analysis; epirubicin; lactate dehydrogenase; predictive factor

Originalsprog	Engelsk
Tidsskrift	Breast Cancer Research and Treatment
Udgave nummer	91
Sider (fra-til)	217-225
ISSN	0167-6806
Status	Udgivet - 2005

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Citationsformater

Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis og 579 patients treated with epirubicin-based chemoterapy. / Ryberg, Marianne; Nielsen, Dorte; Osterlind, Kell et al.

I: Breast Cancer Research and Treatment, Nr. 91, 2005, s. 217-225.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

@article{6d012d4074c311dbbee902004c4f4f50,

title = "Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis og 579 patients treated with epirubicin-based chemoterapy",

abstract = "breast cancer; CNS metastases; competing risk analysis; epirubicin; lactate dehydrogenase; predictive factor",

author = "Marianne Ryberg and Dorte Nielsen and Kell Osterlind and Andersen, {Per Kragh} and T. Skovsgaard and Per Dombernowsky",

year = "2005",

language = "English",

pages = "217--225",

journal = "Breast Cancer Research and Treatment",

issn = "0167-6806",

publisher = "Springer",

number = "91",

}

TY - JOUR

T1 - Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis og 579 patients treated with epirubicin-based chemoterapy

AU - Ryberg, Marianne

AU - Nielsen, Dorte

AU - Osterlind, Kell

AU - Andersen, Per Kragh

AU - Skovsgaard, T.

AU - Dombernowsky, Per

PY - 2005

Y1 - 2005

N2 - breast cancer; CNS metastases; competing risk analysis; epirubicin; lactate dehydrogenase; predictive factor

AB - breast cancer; CNS metastases; competing risk analysis; epirubicin; lactate dehydrogenase; predictive factor

M3 - Journal article

SN - 0167-6806

SP - 217

EP - 225

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

IS - 91

ER -